Skip to content

Clinical trials

Phase 2 Multiple Myeloma trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 2 Country / region: Japan Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20121
20131
20144
20151
20163
20171
20182
20214
20221
20232
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting3
Recruiting3
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
Celgene3
Janssen Research & Development, LLC3
Novartis Pharmaceuticals3
Pfizer2
Sanofi2
SymBio Pharmaceuticals2
AbbVie1
Celgene Corporation1
Genzyme, a Sanofi Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma25
Recurrence5
Neoplasms3
Lymphoma2
Amyloidosis1
Biliary Tract Neoplasms1
Gastrointestinal Stromal Tumors1
Glioma1
Hematologic Neoplasms1
Leukemia, Hairy Cell1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.